INS and diabetes mellitus: Likewise, in the study by Horikawa et al., 83.3% of patients with HNF1B-MODY underwent insulin treatment from the onset of diabetes and could not be withdrawn from insulin treatment, which suggests that insulin secretion deficiency is a characteristic feature of this mutation [17].